News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Bisker-Leib Vered
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/09/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/23/2023 |
4
| Bisker-Leib Vered (Director) has filed a Form 4 on Old Ayala, Inc|
Txns:
| Disposed/sold 8,750 options to buy
@ $10.98, valued at
$96.1k
Disposed/sold 6,250 options to buy
@ $10.35, valued at
$64.7k
Disposed/sold 6,250 options to buy
@ $1.63, valued at
$10.2k
|
|
| 01/23/2023 |
4
| Bisker-Leib Vered (Director) has filed a Form 4 on Ayala Pharmaceuticals, Inc.|
Txns:
| Granted 1,639 options
@ $58.59, valued at
$96k
Granted 1,171 options
@ $55.23, valued at
$64.7k
Granted 1,171 options
@ $8.69, valued at
$10.2k
|
|
| 01/23/2023 |
3
| Bisker-Leib Vered (Director) has filed a Form 3 on Ayala Pharmaceuticals, Inc. |
| 11/25/2022 |
4
| Bisker-Leib Vered (COO) has filed a Form 4 on Compass Therapeutics, Inc.|
Txns:
| Sold 14,929 shares
@ $4.19, valued at
$62.6k
Sold 9,569 shares
@ $4.3, valued at
$41.1k
Sold 2 shares
@ $4.36, valued at
$8.7 |
|
| 11/22/2022 |
4
| Bisker-Leib Vered (COO) has filed a Form 4 on Compass Therapeutics, Inc.|
Txns:
| Sold 6,226 shares
@ $4.4, valued at
$27.4k
Sold 16,035 shares
@ $4.34, valued at
$69.6k
|
|
| 06/15/2022 |
4
| Bisker-Leib Vered (Director) has filed a Form 4 on Ayala Pharmaceuticals, Inc.|
Txns:
| Granted 6,250 options to buy
@ $1.63, valued at
$10.2k
|
|
| 02/23/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 02/18/2022 |
4
| Bisker-Leib Vered (COO) has filed a Form 4 on Compass Therapeutics, Inc.|
Txns:
| Granted 500,000 options to buy
@ $2.52, valued at
$1.3M
|
|
| 11/18/2021 |
4
| Bisker-Leib Vered (COO) has filed a Form 4 on Compass Therapeutics, Inc.|
Txns:
| Granted 600,000 shares
@ $0 |
|
| 06/14/2021 |
4
| Bisker-Leib Vered (Director) has filed a Form 4 on Ayala Pharmaceuticals, Inc.|
Txns:
| Granted 6,250 options to buy
@ $10.35, valued at
$64.7k
|
|
| 03/01/2021 |
4
| Bisker-Leib Vered (President & COO) has filed a Form 4 on Compass Therapeutics, Inc.|
Txns:
| Granted 400,000 options to buy
@ $5, valued at
$2M
|
|
| 08/20/2020 |
4
| Bisker-Leib Vered (Director) has filed a Form 4 on Ayala Pharmaceuticals, Inc.|
Txns:
| Granted 8,750 options to buy
@ $10.98, valued at
$96.1k
|
|
| 08/20/2020 |
3
| Bisker-Leib Vered (Director) has filed a Form 3 on Ayala Pharmaceuticals, Inc. |
| 08/10/2020 |
4
| Bisker-Leib Vered (COO) has filed a Form 4 on Compass Therapeutics, Inc.|
Txns:
| Granted 600,000 options to buy
@ $5, valued at
$3M
|
|
| 06/23/2020 |
3
| Bisker-Leib Vered (COO) has filed a Form 3 on Compass Therapeutics, Inc. |
|
|